EP-342

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEP-342
Drug Alias NameEP-342
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNucleolin modulators
TargetsNucleolin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEsperance Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A